When Crisis Hits, Sanofi Turns To Digital Transformation In China
Executive Summary
Fallout can be an opportunity when both makers and service providers see the need to collaborate to solve China's acute and changing regulatory demand.
You may also be interested in...
GSK Bets On Online-To-Offline Push To Expand Reach In China
GSK’s alliance with AliHealth underscores its belief that the China market has significant room for growth if combined with the right technologies.
Catch Me If You Can: Knowing How To Innovate Matters In China
Given the host of recent and planned policy and regulatory changes in China, the traditional lines between multinational and local companies in the country will become increasingly blurred. These who know how to innovate in different ways in the fast-changing environment will have the most to gain, says the head of one major pharma industry trade group.
DTP Pharmacies March On In China: Pharma Ignores At Its Own Risk
A shift in dispensing from hospitals to external pharmacies has led to predictions that the direct-to-patient sales model will be big in China. But only those with the right partnerships and expertise will reap the benefits, leading pharmacy chain executives told a recent conference.